267 related articles for article (PubMed ID: 11003622)
1. Induction of murine hepatocyte death by membrane-bound CD95 (Fas/APO-1)-ligand: characterization of an in vitro system.
Schlosser SF; Azzaroli F; Dao T; Hingorani R; Crispe IN; Boyer JL
Hepatology; 2000 Oct; 32(4 Pt 1):779-85. PubMed ID: 11003622
[TBL] [Abstract][Full Text] [Related]
2. The chemotherapeutic drug 5-fluorouracil induces apoptosis in mouse thymocytes in vivo via activation of the CD95(APO-1/Fas) system.
Eichhorst ST; Müerköster S; Weigand MA; Krammer PH
Cancer Res; 2001 Jan; 61(1):243-8. PubMed ID: 11196169
[TBL] [Abstract][Full Text] [Related]
3. Hepatocytes as cytotoxic effector cells can induce cell death by CD95 ligand-mediated pathway.
Guy CS; Wang J; Michalak TI
Hepatology; 2006 Jun; 43(6):1231-40. PubMed ID: 16729304
[TBL] [Abstract][Full Text] [Related]
4. Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo.
Ehl S; Hoffmann-Rohrer U; Nagata S; Hengartner H; Zinkernagel R
J Immunol; 1996 Apr; 156(7):2357-60. PubMed ID: 8786290
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes.
Azzaroli F; Mehal W; Soroka CJ; Wang L; Lee J; Crispe IN; Boyer JL
Hepatology; 2002 Jul; 36(1):49-54. PubMed ID: 12085348
[TBL] [Abstract][Full Text] [Related]
6. Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand.
Müller KP; Mariani SM; Matiba B; Kyewski B; Krammer PH
Eur J Immunol; 1995 Oct; 25(10):2996-9. PubMed ID: 7589104
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells.
Matsue H; Edelbaum D; Hartmann AC; Morita A; Bergstresser PR; Yagita H; Okumura K; Takashima A
J Immunol; 1999 May; 162(9):5287-98. PubMed ID: 10228004
[TBL] [Abstract][Full Text] [Related]
8. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.
Eberle J; Fecker LF; Hossini AM; Wieder T; Daniel PT; Orfanos CE; Geilen CC
Oncogene; 2003 Dec; 22(57):9131-41. PubMed ID: 14668794
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis by IFNgamma in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit.
Bernassola F; Scheuerpflug C; Herr I; Krammer PH; Debatin KM; Melino G
Cell Death Differ; 1999 Jul; 6(7):652-60. PubMed ID: 10453076
[TBL] [Abstract][Full Text] [Related]
10. Control of neuronal branching by the death receptor CD95 (Fas/Apo-1).
Zuliani C; Kleber S; Klussmann S; Wenger T; Kenzelmann M; Schreglmann N; Martinez A; del Rio JA; Soriano E; Vodrazka P; Kuner R; Groene HJ; Herr I; Krammer PH; Martin-Villalba A
Cell Death Differ; 2006 Jan; 13(1):31-40. PubMed ID: 16003386
[TBL] [Abstract][Full Text] [Related]
11. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
[TBL] [Abstract][Full Text] [Related]
12. Fas-mediated induction of hepatocyte apoptosis in a neuroblastoma and hepatocyte coculture model.
Chen MK; Strande LF; Beierle EA; Kain MS; Geldziler BD; Doolin EJ
J Surg Res; 1999 Jun; 84(1):82-7. PubMed ID: 10334894
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of CD95L-induced apoptosis of human malignant glioma cells by topotecan involves inhibition of RNA synthesis but not changes in CD95 or CD95L protein expression.
Winter S; Weller M
J Pharmacol Exp Ther; 1998 Sep; 286(3):1374-82. PubMed ID: 9732400
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
Chatterjee D; Schmitz I; Krueger A; Yeung K; Kirchhoff S; Krammer PH; Peter ME; Wyche JH; Pantazis P
Cancer Res; 2001 Oct; 61(19):7148-54. PubMed ID: 11585748
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis of haematopoietic cells upon thymidylate synthase inhibition is independent of p53 accumulation and CD95-CD95 ligand interaction.
Muñoz-Pinedo C; Oliver FJ; López-Rivas A
Biochem J; 2001 Jan; 353(Pt 1):101-108. PubMed ID: 11115403
[TBL] [Abstract][Full Text] [Related]
16. Placenta-derived CD95 ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndrome.
Strand S; Strand D; Seufert R; Mann A; Lotz J; Blessing M; Lahn M; Wunsch A; Broering DC; Hahn U; Grischke EM; Rogiers X; Otto G; Gores GJ; Galle PR
Gastroenterology; 2004 Mar; 126(3):849-58. PubMed ID: 14988839
[TBL] [Abstract][Full Text] [Related]
17. Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo.
Rensing-Ehl A; Frei K; Flury R; Matiba B; Mariani SM; Weller M; Aebischer P; Krammer PH; Fontana A
Eur J Immunol; 1995 Aug; 25(8):2253-8. PubMed ID: 7545115
[TBL] [Abstract][Full Text] [Related]
18. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
Hermisson M; Weller M
Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis.
Li JH; Kluger MS; Madge LA; Zheng L; Bothwell AL; Pober JS
Am J Pathol; 2002 Oct; 161(4):1485-95. PubMed ID: 12368221
[TBL] [Abstract][Full Text] [Related]
20. Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity.
Shimizu M; Fontana A; Takeda Y; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jan; 207(1):41-8. PubMed ID: 11161452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
